Multifunctional nanoparticles for multiplex detection of breast cancer biomarkers

用于乳腺癌生物标志物多重检测的多功能纳米颗粒

基本信息

  • 批准号:
    7612791
  • 负责人:
  • 金额:
    $ 39.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-05-10 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The presence of Her-2, estrogen receptor (ER) or progesterone receptor (P) on breast cancer cells is a very important biomarker which facilitates physicians in making decisions on treatment schemes and in proposing prognosis of the disease. Current methods for diagnostic and prognostic classifications of ER, PR and Her2/neu are based on immunohistochemistry (IHC), a technique that has been used in clinical medicine for over 80 years. However, the immunoenzyme (HRP-based) IHC method has a single color nature and is unable to perform multiplexed molecular profiling. Moreover, IHC remains semi-quantitative and subjective, resulting in considerable inter-observer variations of results. Semiconductor nanocrystals also known as quantum dots (QDs) are a new class of biological detection labels, which present a broad range of biomedical applications including multicolor labeling, single molecule biophysics, biomolecular profiling, optical barcoding, and in vitro and in vivo imaging. Current studies have indicated that QDs can be used for multiplex detection of ER, PR and Her2 in breast tumor tissue. In Phase I work, we have demonstrated that genetic engineered protein G fragment can serve as universal linker to conjugate nanoparticles with antibodies, which presented the probes with small size and antibody orientation. In phase II, we will first separate the circulating cancer cells and then quantitatively analyze the expression levels of ER, PR and Her2/neu biomarkers in a multiplexed fashion. Our overall goal is to develop an assay that is capable of isolating circulating cancer cells while quantifing the expression levels of a panel of cancer biomarkers to provide guidance for cancer treatment. 1 PUBLIC HEALTH RELEVANCE: Breast cancer is the second leading cause of death in the United States. In 2007, about 1,444,920 new cancer cases were expected to be diagnosed, and about 559,650 Americans were expected to die of cancer-more than 1,500 people per day. The presence of several important biomarkers on breast cancer cells is a very important diagnostic criterion, which facilitates physicians in making decisions on treatment schemes and in proposing prognosis of the disease. However it has been difficult to accurately, simultaneously measure the expression levels of these receptors. The development of nanotechnology, especially the development of bioconjugated nanoparticles provides an essential solution. Successful development of this project will significantly advance the technique of multiplex quantification of expression levels of various cancer receptors and provide valuable guidance for more effective treatments.
描述(由申请人提供):乳腺癌细胞上Her-2、雌激素受体(ER)或孕激素受体(P)的存在是一种非常重要的生物标志物,有助于医生决定治疗方案和提出疾病的预后。目前用于ER、PR和Her 2/neu的诊断和预后分类的方法基于免疫组织化学(IHC),这是一种已在临床医学中使用超过80年的技术。然而,免疫酶(基于HRP)IHC方法具有单一颜色性质,无法进行多重分子分析。此外,IHC仍然是半定量和主观的,导致观察者之间的结果存在相当大的差异。半导体纳米晶体也称为量子点(QD),是一类新的生物检测标记,其呈现广泛的生物医学应用,包括荧光标记、单分子生物物理学、生物分子谱、光学条形码以及体外和体内成像。目前的研究表明,量子点可用于乳腺肿瘤组织中ER、PR和Her 2的多重检测。在第一阶段的工作中,我们已经证明,基因工程蛋白G片段可以作为通用的连接器,以结合纳米粒子与抗体,这提出了小尺寸和抗体的方向的探针。在第二阶段,我们将首先分离循环癌细胞,然后以多重方式定量分析ER,PR和Her 2/neu生物标志物的表达水平。我们的总体目标是开发一种能够分离循环癌细胞的检测方法,同时定量一组癌症生物标志物的表达水平,为癌症治疗提供指导。1公共卫生相关性:乳腺癌是美国第二大死亡原因。2007年,预计将诊断出约1,444,920例新的癌症病例,约559,650名美国人预计将死于癌症-每天超过1,500人。乳腺癌细胞上几种重要生物标志物的存在是一个非常重要的诊断标准,它有助于医生决定治疗方案和提出疾病的预后。然而,很难准确地同时测量这些受体的表达水平。纳米技术的发展,特别是生物结合纳米颗粒的发展提供了一个必不可少的解决方案。该项目的成功开发将显著推进多种癌症受体表达水平的多重定量技术,并为更有效的治疗提供有价值的指导。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yongqiang Andrew Wang其他文献

Yongqiang Andrew Wang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yongqiang Andrew Wang', 18)}}的其他基金

Supplementary for Assessment of Microvessel Density and Tumor Proximity for Prognosis of Cancer
评估微血管密度和肿瘤邻近性以评估癌症预后的补充
  • 批准号:
    9194361
  • 财政年份:
    2014
  • 资助金额:
    $ 39.51万
  • 项目类别:
Assessment of microvessel density and tumor proximity for prognosis of cancer
评估微血管密度和肿瘤邻近性对癌症预后的影响
  • 批准号:
    8647495
  • 财政年份:
    2014
  • 资助金额:
    $ 39.51万
  • 项目类别:
Magnetic Nanoparticles and Quantum Dots for Diagnosis of Early Stage Ovarian Canc
磁性纳米颗粒和量子点用于诊断早期卵巢癌
  • 批准号:
    8110007
  • 财政年份:
    2010
  • 资助金额:
    $ 39.51万
  • 项目类别:
Application of QDs-based nanotyping technology in the evaluation of chemotherapy
基于量子点的纳米分型技术在化疗评价中的应用
  • 批准号:
    7746654
  • 财政年份:
    2009
  • 资助金额:
    $ 39.51万
  • 项目类别:
Iron oxide nanoparticle probes for target specific MR molecular imaging
用于目标特异性 MR 分子成像的氧化铁纳米颗粒探针
  • 批准号:
    7611718
  • 财政年份:
    2009
  • 资助金额:
    $ 39.51万
  • 项目类别:
Nanoparticle-based Mannetic Microluidic Enrichment System (MMES)
基于纳米颗粒的磁力微流控富集系统 (MMES)
  • 批准号:
    7483314
  • 财政年份:
    2008
  • 资助金额:
    $ 39.51万
  • 项目类别:
Development of Cadmium-free and Multicolor Quantum Dots as Lifetime Imaging Probe
开发无镉多色量子点作为终身成像探针
  • 批准号:
    7483313
  • 财政年份:
    2008
  • 资助金额:
    $ 39.51万
  • 项目类别:
Nanoparticle Based Magnetic Microfluidic concentrator (MMC)
基于纳米颗粒的磁微流控浓缩器 (MMC)
  • 批准号:
    7348254
  • 财政年份:
    2008
  • 资助金额:
    $ 39.51万
  • 项目类别:
Multifunctional nanoparticles for multiplex detection of breast cancer biomarkers
用于乳腺癌生物标志物多重检测的多功能纳米颗粒
  • 批准号:
    7939574
  • 财政年份:
    2006
  • 资助金额:
    $ 39.51万
  • 项目类别:
Adaptor Protein-Quantum Dot Conjugates as Biological Labels
接头蛋白-量子点缀合物作为生物标记
  • 批准号:
    7110878
  • 财政年份:
    2006
  • 资助金额:
    $ 39.51万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 39.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 39.51万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 39.51万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 39.51万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 39.51万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 39.51万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 39.51万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 39.51万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 39.51万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 39.51万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了